Kwality Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE552U01010
  • NSEID: KPL
  • BSEID: 539997
INR
4,135.90
-154.05 (-3.59%)
BSENSE

Nov 20

BSE+NSE Vol: 50.93 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1002639,
    "name": "Kwality Pharma",
    "stock_name": "Kwality Pharma",
    "full_name": "Kwality Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/kwality-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "4,135.90",
    "chg": -154.05,
    "chgp": "-3.59%",
    "dir": -1,
    "prev_price": "4,289.95",
    "mcapval": "4,348.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 539997,
    "symbol": "KPL",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE552U01010",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "50.93 k",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/kwality-pharma-1002639-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Kwality Pharmaceuticals Surges 8.14%: 7 Key Developments Fueling the Rally",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/kwality-pharmaceuticals-surges-814-7-key-developments-fueling-the-rally-4270406",
        "imagepath": "",
        "date": "2026-11-21 14:00:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Nov:</strong> Stock surges 5.86% to Rs.4,048.75 on strong momentum</p>\n                    <p><strong>18 Nov:</strong> New 52-week high at Rs.4,235 and all-time high near Rs.4,189.80</p>\n                    <p><strong>19 Nov:</strong> Hits fresh 52-week and all-time high at Rs.4,274.75</p>\n                    <p><strong>20 Nov:</strong> Upgraded to Buy rating by MarketsMOJO amid strong fundamentals</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.3,824.45</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><di..."
      },
      {
        "title": "Kwality Pharmaceuticals Ltd Hits All-Time High of Rs 4,274.75 as Momentum Builds Across Timeframes",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-hits-all-time-high-at-rs427475-4267811",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/KwalityPharmace_priceRelatedfactors_4267811.png",
        "date": "2026-11-19 09:36:35",
        "description": "Extending its remarkable rally, Kwality Pharmaceuticals Ltd touched a fresh all-time high of Rs 4,274.75 on 19 Nov 2026, marking a significant milestone in its market journey. This surge comes amid sustained outperformance against the broader Sensex and a bullish technical backdrop."
      },
      {
        "title": "Kwality Pharmaceuticals Ltd Sees Bullish Momentum Shift Amid Mixed Technical Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-sees-bullish-momentum-shift-amid-mixed-technical-signals-4267538",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/KwalityPharmace_technicaldot_4267538.png",
        "date": "2026-11-19 08:05:03",
        "description": "Kwality Pharmaceuticals Ltd has experienced a notable shift in price momentum, moving from a mildly bullish to a bullish technical trend, supported by a strong daily moving average and positive monthly indicators despite some bearish weekly signals. The stock’s recent surge to ₹4,195.25, up 3.76% on the day, reflects renewed investor confidence amid mixed technical readings."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Kwality Pharmaceuticals Ltd to 52-Week High of Rs 4235",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-hits-new-52-week-high-at-rs4235-4267314",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/KwalityPharmace_priceRelatedfactors_4267314.png",
        "date": "2026-11-18 15:36:25",
        "description": "Surging from a 52-week low of Rs 851.95 to a new peak of Rs 4235, Kwality Pharmaceuticals Ltd has delivered an extraordinary 344.61% return over the past year, vastly outperforming the Sensex’s decline of 3.12%. This remarkable rally culminated in a fresh 52-week high on 18 Nov 2026, driven predominantly by a confluence of strong technical signals and sustained price momentum."
      },
      {
        "title": "Kwality Pharmaceuticals Ltd Hits All-Time High of Rs 4,217.40 as Momentum Builds Across Timeframes",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-hits-all-time-high-amid-robust-performance-4267309",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/KwalityPharmace_priceRelatedfactors_4267309.png",
        "date": "2026-11-18 15:18:15",
        "description": "Extending its remarkable rally, Kwality Pharmaceuticals Ltd surged 4.31% on 18 Nov 2026 to touch a fresh all-time high of Rs 4,217.40, significantly outpacing the Sensex which declined 0.61% on the same day."
      },
      {
        "title": "Kwality Pharmaceuticals Ltd Sees Mixed Technical Signals Amid Strong Price Momentum",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-sees-mixed-technical-signals-amid-strong-price-momentum-4264690",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/KwalityPharmace_technicaldot_4264690.png",
        "date": "2026-11-17 08:03:20",
        "description": "Kwality Pharmaceuticals Ltd has exhibited a notable shift in price momentum, with its share price surging over 5.8% in a single day to ₹4,048.75. Despite this robust price action, technical indicators present a nuanced picture, reflecting a transition from a bullish to a mildly bullish trend. Investors and analysts are closely monitoring these mixed signals to gauge the stock’s near-term trajectory within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Kwality Pharmaceuticals Ltd is Rated Buy",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/kwality-pharmaceuticals-ltd-is-rated-buy-4262362",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/KwalityPharmace_mojoScore_4262362.png",
        "date": "2026-11-15 10:10:29",
        "description": "Kwality Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 11 November 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 15 November 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Kwality Pharmaceuticals Gains 4.92%: 6 Key Factors Driving the Week’s Momentum",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/kwality-pharmaceuticals-gains-492-6-key-factors-driving-the-weeks-momentum-4261696",
        "imagepath": "",
        "date": "2026-11-14 13:01:41",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Nov 09:</strong> New 52-week high at Rs.3,880</p>\n                    <p><strong>Nov 11:</strong> All-time high reached at Rs.3,930</p>\n                    <p><strong>Nov 12:</strong> New 52-week and all-time high at Rs.4,065.90</p>\n                    <p><strong>Nov 13:</strong> Week closes at Rs.3,824.45 (-2.99% on day)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.3,645.05</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.3,824.45</div><div class=\"stat-change positive\">+4.92%</d..."
      },
      {
        "title": "375% Return in One Year, 115% Profit Growth: What Drives Kwality Pharmaceuticals Ltd’s Multibagger Surge?",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-a-multibagger-stock-defying-market-trends-with-exceptional-returns-4258666",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/KwalityPharmace_multibagger_4258666.png",
        "date": "2026-11-11 18:25:04",
        "description": "A 375.49% stock return in one year. Net profit growth of 114.93% over the same period. The gap between these two figures highlights a significant rerating of Kwality Pharmaceuticals Ltd, with the market paying a much higher multiple for its earnings. This analysis explores how much of the rally is grounded in fundamentals and what the valuation metrics reveal about the sustainability of this surge."
      }
    ],
    "total": 118,
    "sid": "1002639",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/kwality-pharmaceuticals-1002639"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "16-Nov-2026",
      "details": "Newspaper Publication of Unaudited Financial Results for the quarter and half year ended September 30 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "16-Nov-2026",
      "details": "Transcript of Earnings Conference Call - Q2FY2027",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "14-Nov-2026",
      "details": "Intimation under Regulation 30 of the SEBI (LODR)",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Kwality Pharmaceuticals Ltd has declared <strong>6%</strong> dividend, ex-date: 05 Jan 17",
          "dt": "2017-01-05",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Kwality Pharmaceuticals Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 11 Oct 17",
          "dt": "2017-10-11",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

16-Nov-2026 | Source : BSE

Newspaper Publication of Unaudited Financial Results for the quarter and half year ended September 30 2026

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

16-Nov-2026 | Source : BSE

Transcript of Earnings Conference Call - Q2FY2027

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

14-Nov-2026 | Source : BSE

Intimation under Regulation 30 of the SEBI (LODR)

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Kwality Pharmaceuticals Ltd has declared 6% dividend, ex-date: 05 Jan 17

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Kwality Pharmaceuticals Ltd has announced 1:1 bonus issue, ex-date: 11 Oct 17

stock-summary
RIGHTS

No Rights history available